Circulating Mirnas As Non-invasive Markers for Diagnosis and Staging in Prostate Cancer

The present invention relates to a method for staging prostate cancer in a subject suffering from prostate cancer, said method comprises (a) determining the amount of at least one miRNA selected from the group consisting of miRNA-375, miRNA-141, miRNA-200b, miRNA-516a-3p and miRNA9*, or the amount of a precursor molecule in a sample from said patient and (b) comparing the, thus, determined amount with a reference amount. Moreover, the present invention is concerned with a method for identifying a subject susceptible to prostate cancer therapy and to a method for diagnosing prostate cancer. Further envisaged by the present invention are a kit and a device adapted to carry out the method of the present invention.

Patents:
WO 2,011,051,471

Inventor(s): BRASE JAN CHRISTOPH [DE]; SUELTMANN HOLGER [DE]; KUNER RUPRECHT [DE]; JOHANNES MARC [DE]; BEISSBARTH TIM [DE]; FAELTH MARIA [SE]

Type of Offer: Sale



« More Medical Patents

---